A comparison of reboxetine and amitryptilline in the treatment of fibromyalgia syndrome with co-morbid depressive symptoms: An open-label preliminary study
Klinik Psikofarmakoloji Bulteni, vol.20, no.1, pp.29-37, 2010 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 20 Issue: 1
- Publication Date: 2010
- Doi Number: 10.1080/10177833.2010.11790631
- Journal Name: Klinik Psikofarmakoloji Bulteni
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.29-37
- Keywords: Antidepressants, fibromyalgia, amitryptilline, reboxetine, NOREPINEPHRINE REUPTAKE INHIBITOR, PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND, NEUROPATHIC PAIN, VENLAFAXINE TREATMENT, MAJOR DEPRESSION, TURKISH VERSION, CLINICAL-TRIAL, AMITRIPTYLINE, ANXIETY
- Hacettepe University Affiliated: No